Continental Grain-backed Perfect Day has raised a further $160m for a round that increased the vegan dairy protein developer's overall funding to more than $360m.

The finance management software developer raised $28.5m in its third round in the past year, to increase its overall funding to $85m.

The GLP-backed international logistics provider raised $71.1m in a Taikang-led round that will support a global expansion.

Novo, Pfizer and Nan Fung helped provide $93.5m for the Stanford immunotherapy spinout as it advances its lead asset towards the clinic.

Novo, Pfizer and Nan Fung helped provide $93.5m for the cancer treatment developer as it advances its lead product candidate towards the clinic.

Wells Fargo led a $41.5m round for the tech-equipped property manager that included existing backers Canaan Partners, Lightspeed Venture Partners and Jackson Square Ventures.

Samsung Catalyst Fund, BBVA, SBI Group and ABN Amro Ventures chipped in as the banking platform developer raised $67.3m at a $360m valuation.

The pharmaceutical company co-led a series C round for AAV gene therapy developer Freeline that took its total funding to $275m.

Microsoft's M12 unit and CreditEase Israel Innovation Fund returned for a series C round that took the container coding platform developer's overall funding to $42m.

Syncona supplied a third of the investment and retains a majority stake in Freeline, which is based on research at UCL.